It has been suggested that hepatitis B virus (HBV) X gene activates X gene expression by disrupting the function of p53 tumor suppressor gene (Takada et al., 1996) . To ®nd out their connection, eect of X protein expression on the nuclear localization of p53 protein in human hepatoma cells was examined by the immunouorescent double-staining technique. The location of transiently-expressed p53 protein was examined in X gene-transfected cells, where X protein was detected in the cytoplasm. The nuclear location of transientlyexpressed p53 protein was changed to the cytoplasm by X protein co-expression. Endogenous p53 protein was also observed in the cytoplasm by X protein expression. The transcriptional activation domain of X protein and the carboxy-terminal region of p53 protein were found mutually responsible for the cytoplasmic retention of p53 protein in X gene-transfected cells. Therefore, the cytoplasmic retention of p53 protein may be closely correlated to the function of X protein expressed in transfected cells.
Introduction
Hepatitis B virus (HBV) is closely related not only to acute or chronic hepatitis, but also to the development of hepatocellular carcinoma (HCC) (for review, see Ganem and Varmus, 1987; Tiollais et al., 1985) . One of the HBV genes X, codes a basic protein of 154 amino acids, which has been implicated in the carcinogenicity of this virus as a potential causative factor because of its ability to induce transformation of rodent cells (Hohne et al., 1990; Rakotomahanina et al., 1994; Shirakata et al., 1989) and to cause development of HCC in transgenic mice (Kim et al., 1991) . The X gene is known to activate transcription of viral and many cellular genes (Spandau and Lee, 1998; for review, Rossner, 1992) .
In recent years, the transcriptional activation function of X protein was studied extensively by a number of investigators and some of its functional bases have been revealed, although the reported observations and proposed mechanisms have not been consistent. Many reports suggest that X protein activates transciption via protein-protein intereaction with cellular factors which bind to enhancer sequences. There are also a few reports suggesting that X protein activates some signal transduction factors (Benn and Schneider, 1994; Cross et al., 1993; Kekule et al., 1993; Natoli et al., 1994b) or DNA binding of some transcription factors (Natoli et al., 1994a) .
Although normal X protein is known to activate transcription of many genes through various enhancer elements, such as AP-1 and AP-2 binding sequences in SV40 enhancer (Seto et al., 1990) , kB-like sequences in HIV-LTR (Siddiqui et al., 1989; Twu et al., 1989) and the 26 bp XRE (X-responsive element) in the HBV enhancer I (Faktor and Shaul, 1990) , our previous data indicate that the X responsive element is also present in the X gene basal promoter (Takada et al., 1996) . In addition, it was reported that X protein contained the Kunitz inhibitor (KI) domain-like region against serine proteases, which is indispensable for activation function of the X protein (Takada et al., 1994a; Takada and Koike, 1990b) (Figure 1 ).
Based on the general acceptance that the tumor suppressor gene p53 product activates or represses transcription of a variety of viral and cellular genes by directly interacting with the transcritpion factors and/ or DNA (Farmer et al., 1992; Kern et al., 1992; Ragimov et al., 1993; Seto et al., 1992; Thut et al., 1995; Zambetti et al., 1992) , we previously focused on how the p53 gene regulates X gene expression. The basal promoter of the X gene was found to be negatively regulated by transfected p53 gene, but not by its mutants. Moreover, when the p53 gene was transfected together with the X gene, the negative eect of p53 gene was counteracted by X protein coexpression (Takada et al., 1994b (Takada et al., , 1996 . On the other hand, growth regulatory genes, such as p21WAF1/Cip1 (El-Deiry, 1994), cyclin G (Okamoto and Beach, 1994) , the muscle creatine kinase gene promoter (Weintraub et al., 1991; Zambetti et al., 1992) or the PG13-CAT (Kern et al., 1991; Wang et al., 1994) , were positively regulated under similar conditions. (Takada et al., 1994b (Takada et al., , 1996 .
In most human tumor cells studied, p53 gene abnormalities lead to loss of the p53 protein or to the expression of mutant forms of the protein without DNA binding activity (Baker et al., 1990; Kern et al., 1991; Takahashi et al., 1989; Zambetti et al., 1992) . The state of the p53 gene has been studied previously in human hepatoma cell lines, and its structure and expression in HepG2 and HuH7 cells were explored (Bressac et al., 1990) . Although the p53 protein in HepG2 cells was normal and the half-life was short, it was not normal in HuH7 cells, where the p53 protein half-life was markedly increased. In HuH7 cells, the p53 protein exhibits inability of DNA binding due to a point mutation in its DNA binding domain other than the carboxy-terminal region.
Disruption of p53 activity by interaction with viral oncoproteins or cellular proteins has been implicated in the development of some human cancers. It has been reported that HBV X protein physically associated with p53 protein and apparently blocks its normal function in vitro (Feitelson et al., 1993; Wang et al., 1994) . Subsequently, it has been indicated that liver tumor development in the X transgenic mouse is probably correlated with p53 binding to X protein in the cytoplasm and blockage of p53 entry into nucleus (Ueda et al., 1995) . However, there has been no evidence to indicate that transient expression of X gene is able to inhibit p53 entry into nucleus in the cell culture system. As it is known that normal or mutant p53 protein is located in the nucleus (Shaulsky et al., 1991) and that X protein is found in the cytoplasm (Benn and Schneider, 1994; Siddiqui et al., 1987) , we examined whether or not transient expression of X protein eects on the intra-cellular location of p53 protein, using X gene-transfected human hepatoma cells by the immuno¯uorescent double-staining technique. This study clearly revealed that expression of normal X protein changed the location of transiently-expressed p53 protein and endogenous p53 protein from the nucleus to the cytoplasm in the transient expression system. This change depended on both the carboxy-terminal region of p53 protein and the transcriptional activation domain of X protein (Figure 1 ). The results of present investigation imply that the instrinsic function of X protein may induce a change in the location of p53 protein from the nucleus to the cytoplasm in the X gene-transfected cells.
Results

X gene co-transfection blocks nuclear localization of transiently-expressed p53 protein
As it is known that nuclear localization is essential for p53 protein to function (Shaulsky et al., 1991) , we examined the eect of X protein co-expression on the intra-cellular location of transiently-expressed normal P53 protein in p53 gene-transfected HepG2 cells using the immuno¯uorescent double-staining technique. When the p53 expression plasmid was transfected alone to the HepG2 cells and the location of p53 protein was analysed, over-expression of p53 protein was always detected in the nucleus by means of the intense nuclear staining (Figure 2a and c) , as compared to the weak nuclear staining of endogenous p53 protein in HepG2 cells (data not shown). Furthermore, it should be mentioned that over-expression of transiently-expressed p53 protein was seen in binucleated cells at 22.9% frequency among total mononucleated and binucleated p53 protein-expressing cells (11/48) ( Table 1) , under conditions similar to those of the CAT assay to examine the transcriptional activation function of X protein (Takada et al., 1996) . Besides, the percentage of binucleated cells was about 21% in the Table 1 ). On the other hand, expression of X protein was seen in binucleated cells at 50.8% frequency among total X-expressing cells (31/61) ( Table 1 ). Present data suggest that expression of X protein may stimulate cell growth, resulting in an increased appearance of binucleated cells.
Interestingly, when X protein-expressing plasmid was transfected together with p53 expressing plasmid, transiently-expressed normal p53 protein and X protein were found in the cytoplasm of mononucleated or binucleated cells (Figure 2d and f and Table  1 ). Intense staining of X protein was observed in porportion to the eciency of DNA transfection and was sometimes corresponded to a granular dense structure at the nuclear periphery in the phasecontrast micrograph as will be seen later. X protein stayed consistently in the cytoplasm irrespective of the presence or the absence of transiently-expressed p53 protein in cells ( Figure 2e and Table 1 ). But, the distribution of X protein was partly coincided with that of p53 in the cytoplasm (Figure 2e and f) . Similar to the frequency of 50.8% of X protein alone, frequency of p53 protein expression in the cytoplasm of binucleated X protein-expressing cells was 51.9% (27/52) among total cells, in which p53 protein and X protein were expressed in the cytoplasm of mononucleated or binucleated cells (Table 1) . A reason why the p53 protein-expressing cells frequently coincided with the X protein expressing cells could be explained by the fact that the amount of transfected X gene expression plasmid was ten times higher than that of p53 gene expression plasmid.
These observations prompted us to clarify again whether this function of X protein is related to a particular region of X protein. A mutant X protein DRsaI deleted the activation domain at the carboxyterminal end region (Figure 1 ) and exhibited no transcriptional activation function (Arii et al., 1992; Takada et al., 1996; Koike, 1990b, 1994) . This DRsaI mutant was examined to detect its ability to change the location of transiently-expressed normal p53 protein from the nucleus to the cytoplasm. Although the DRsaI protein was expressed in the cytoplasm, as shown in Figure 3a and b, the DRsaI mutant had no eect on the nuclear location of normal p53 protein over-expressed in two adjacent cells among others (Figure 3c ), despite the presence of mutant DRsaI protein was seen in the cytoplasm of one of two adjacent cells (Figure 3b) . Results indicate that normal X protein may play a role in the cytoplasmic retention of p53 protein in X genetransfected cells by blocking its translocation from the cytoplasm to the nucleus. Incidentally, some nuclear proteins such as c-myc and PCNA, exhibited no signi®cant change in their nuclear location in Xgene transfected cells (data not shown).
Then, a region of p53 protein essential for its response to normal X protein was also analysed using HepG2 cells and mutant gene p53d(346 ± 393), that deleted the carboxy-terminal region (aa 346 ± 393) harboring oligomerization and basic domains (Reed et al., 1995) , but still retained the principal nuclear localization signal (NLS I) (Shaulsky et al., 1991) . The mutant protein p53d(346 ± 393) was found in the nucleus irrespective of the absence (Figure 4b and c) or the presence (Figure 4e and f) of X gene coexpression. Another mutant OM1 is a point mutant of p53 protein, where Glu (aa266) was replaced by Gly in the DNA binding domain (Sakai and Tsuchida, 1992) . This mutant protein was detected in the nucleus when expressed alone. However, OM1 protein was located in the cytoplasm in the X gene-transfected HepG2 cells (data not shown). The present data suggest that the carboxy-terminal region (aa 346 ± 393) of p53 protein is necessary in relation to mutual interaction through the activation domain of normal X protein in the cotransfected cells, although there is no concrete evidence so far for direct interaction in vivo. All results are again consistent with the indication that the function of normal X protein may correlate with the retention of p53 protein harboring its carboxy-terminal region (aa 346 ± 393) in the cytoplasm of the HepG2 cell. We also examined the eect of normal X protein expression on the intra-cellular location of endogenous p53 protein using human hepatoma HuH7 cells by immuno¯uorescent double-staining. As the endogenous p53 protein was mutated in its DNA binding domain (Bressac et al., 1990) and relatively visible in the nucleus of the HuH7 cells (Figure 5a and c) as compared to that of the HepG2 cells (data not shown), subsequent examinations on the endogenous p53 protein were performed by using HuH7 cells. In all of the HuH7 cells, so far examined, the endogenous p53 protein was found to be located in the nucleus (Figure 5c ). However, X gene transfection changed the location of endogenous p53 protein from the nucleus to the cytoplasm in the cell (as indicated by N with arrow in Figure 5f ), where normal X protein was expressed in the cytoplasm (Figure 5e ). Dispersed staining of the endogenous p53 protein in the cytoplasm was always detected in every X protein-expressed cell, under conditions similar to those of the CAT assay to examined the transcriptional activation function of X protein (Takada et al., 1996) . Intense staining of X protein was observed in porportion to the eciency of DNA transfection and was sometimes corresponded to a granular dense structure at the nuclear periphery in the phase-contrast micrograph (Figure 5d ). And, the distribution of X protein was partly coincided with that of endogenous p53, whose location was dispersed in the cytoplasm (Figure 5e and f). Data suggest that X gene expression is able to change the location of endogenous p53 protein from the nucleus to the cytoplasm irrespective of the presence of a point mutation in the DNA binding domain of p53 protein of HuH7 cells. These observations also prompted us to clarify whether this intra-cellular action of X protein is related to the transcriptional activation domain. The mutant X protein (DRsaI) was again examined to detect its ability to change the location of endogenous p53 protein from the nucleus to the cytoplasm in HuH7 cells. The DRsaI mutant was expressed in the cytoplasm (Figure 6a and b) , but had no eect on the nuclear location of endogenous p53 protein ( Figure  6c ). On the other hand, the dAvaI/AvaI mutant (Figure 1) , that deleted the amino-terminal region (Arii et al., 1992; Takada et al., 1996; Koike, 1990b, 1994) , but still retained the transcriptional activation function, was expressed in the cytoplasm (Figure 6d and e) and able to change the location of endogenous p53 protein from the nucleus to the cytoplasm (as indicated by N with arrow in Figure   Figure 4 Intra-cellular location of transiently-expressed mutant p53 protein in normal X gene-transfected HepG2 cells. HepG2 cells were transfected with 0.1 mg of mutant p53 gene expression plasmid, pCMV53d (346 ± 393), alone or in combination with 1 mg of normal X expression plasmid, pEFX, and double-stained with Texas Red and FITC. Each set of left and right panels shows phase-contrast and¯uorescent micrographs of the same ®eld, with pCMVp53d (346 ± 393) along (left) or in combination with pEFX (right). Upper panels (a and d) show phase-contrast micrographs. Middle (b and e) and lower panels (c and f) show the expression of normal X protein and mutant p53 protein, respectively. N and arrow indicate the location of nuclei Figure 5 Intra-cellular location of endogenous p53 protein in normal X gene-transfected HuH7 cells. HuH7 cells were transfected with 1 mg of normal X gene expression plasmid, pEFX. Transiently-expressed X protein and endogenous p53 protein were double-stained with Texas Red and FITC. In the upper panels (a and d), un-transfected HuH7 cells respectively, were photographed by phase-contrast microscopy. In the middle panels (b and e), X protein was visualized with Texas Red staining. In the lower panels (c and f), endogenous p53 protein was visualized with FITC staining. Each set of left and right panels shows dierent micrographs of the same ®eld, where 1 mg of normal X gene expression plasmid, pEFX, was transfected (right panel) or un-transfected (left panel). N and arrow indicate the location of nuclei 6f). Results suggested that the activation domain of X protein plays a role in the retention of endogenous p53 protein in the cytoplasm. All observations support the notion that the function of X protein may correlate with the cytoplasmic retention of p53 protein in X gene-transfected cells.
Discussion
We previously found that the X gene basal promoter was negatively regulated by p53 gene, and that the negative eect of p53 gene was counteracted by X protein co-expression, thus the function of X gene may be explained by the interference of p53 function with X protein (Takada et al., 1996) . Immuno¯uorescent staining revealed that functional disruption of the p53 gene by co-transfected X gene closely correlated with the change in the location of transiently-expressed or endogenous p53 protein from the nucleus to the cytoplasm, but not vice versa. In addition, the activation domain of X protein was found to be involved in the cytoplasmic retention of p53 protein.
Based on the present results, we could speculate the existence of a speci®c process that mediates nuclear import of p53 protein by manifesting a nuclear localization signal (NLS). Recently, Wang et al. (1994) reported that X protein modulated the transcriptional regulatory function of p53 protein through a p53 binding element (Feitelson et al., 1993; Wang et al., 1994) , however, there is no evidence to indicate concomitant accumulation of X protein in the nucleus instead of cytoplasmic localization by directly binding to nuclear p53 protein. X protein was able to change the location of mutated p53 protein with respect to the DNA binding domain from the nucleus to the cytoplasm in the HuH7 cells. As the distribution of X protein was partly coincided with the dispersed location of p53 in the cytoplasm, direct interaction between the activation domain of X protein and the carboxy-terminal region (aa 346 ± 393) of p53 protein remains to be elucidated. It was found recently that coexpression of myc and bcl-2 changed the localization of p53 protein from the nucleus into the cytoplasm in the G1 cell cycle phase and inhibited p53-induced apoptosis of mouse erythroleukemia (MEL) cells (Ryan et al., 1994) . Immunocytochemical staining patterns of bcl-2 associating protein (Nip) and adenovirus E1B 19 kDa protein (Boyd et al., 1994) appear to be similar to those of X protein. A common pathway for their p53 inhibitory function of these proteins might be present. However, change of subcellular localization of p53 protein in the cell cycle has not been extensively studied.
Although HuH7 cells contain p53 protein with a point mutation in the DNA binding domain, X protein was still able to change the location of this mutant p53 protein from the nucleus to the cytoplasm. The cytoplasmic retention of p53 protein in the X genetransfected cells may be closely connecting to the function of X protein through the carboxy-terminal region (aa 346 ± 393) of p53 protein. In addition, normal X protein seems to have some counteracting eect on the p53 suppressor function similar to that of oncogene products of other DNA tumor viruses, such as SV40 T antigen, human papilloma virus E6 and adenovirus E1B. The function of X protein on the hepatocarcinogenesis may not be correlated with the mutation of p53 protein, but may be correlated with the retention of normal p53 protein in the cytoplasm instead of the nucleus, resulting in genetic instability in the cell.
It has been reported that transcriptional activation by X protein is observed according to the cell type (Rossner, 1992; Seto et al., 1992) . In this respect, it should be noted that a normal state of p53 protein in the nucleus may be one of the dominant determinants of the cell type speci®city for the occurrence of transcriptional activation. Further elucidation of the mechanism, where the X protein changes the location of p53 protein from the nucleus into the cytoplasm, may prove to be fruitful in understanding the pleiotropic eects of normal X protein as well as the regulatory mechanism of nuclear translocation of p53 protein in the cell cycle.
Materials and methods
Plasmid DNA
Construction of the X gene expression plasmids, pHBVX-1 and ORF (open reading frame) mutants, was carried out as described previously (Kobayashi and Koike, 1984; Takada et al., 1996; Takada and Koike, 1990a) (Figure 1 ). The 0.87 kb StuI ± BgIII (nt.872 ± 1858) fragment of HBV DNA containing the X gene expression unit inserted into the BamHI site of pBR322 was subjected to various constructions for the X gene expression plasmids (Takada et al., 1996) . X gene expression plasmids, pEFX and pEFX-DRsaI or pEFX-dAvaI/AvaI, were used as normal and mutant X Figure 6 Intra-cellular location of endogenous p53 protein in mutant X gene-transfected HuH7 cells. HuH7 cells were transfected with 1 mg mutant X gene expression plasmid, pEFXDRsaI or pEFX-dAvaI/AvaI. Transiently-expressed mutant X protein, DRsaI or dAvaI/AvaI, and endogenous p53 protein were double-stained with Texas Red and FITC. Upper and lower panels show the dierent micrographs of the same ®eld, where cell nuclei or mutant X protein and endogenous p53 protein were visualized with phase-contrast or¯uorescent microscopy. Left panels (a and d): phase-contrast micrographs. Middle panels (b and e) and right panels (c and f):¯uorescent micrographs with Texas Red staining and FITC staining, respectively. N and arrow indicate the location of nuclei gene expression plasmids, respectively, where normal X ORF and mutant X ORFs, DRsaI and dAvaI/AvaI (Arii et al., 1992) , were driven under the control of the EF1a (elongation factor 1a) gene promoter (Kim et al., 1990) . The p53 gene expression plasmids, pCMVp53 and pCMVOM1 or pCMVp53d(346 ± 393), were constructed by inserting normal or mutant p53 ORF into a CMV vector, respectively (CLONTECH). OM1 is a point mutant of p53, where Glu was replaced by Gly (aa 266) (Sakai and Tsuchida, 1992) . A mutant p53, p53d(346 ± 393), has lost the C-terminal region from aa 346 to the C-terminus (Tsutsumi-Ishii et al., 1995) .
Cell line and DNA transfection
HuH7 cell was derived from human HCC (Nakabayashi et al., 1982) , where HBV infection was negative. HepG2 cell was obtained from hepatoblastoma (Knowles et al., 1980) and was negative for HBV integration. These hepatoma cells were maintained in the DM-160AU medium supplemented with 10% calf serum and 60 mg kanamycin/ ml, then used as recipients of DNA transfection. For the transient expression of transfected recombinant HBV DNA, DNA transfection was carried out by precipitation with calcium phosphate (Graham and van der Eb, 1973) using the indicated amount of each plasmid DNA. The cells were plated at a density of 3610 6 /100 mm dish for 24 h before transfection, and incubated with DNA precipitates for 6 h at 378C.
Immuno¯uorescent double-staining of cells
Cells were seeded on a slide¯ask (Nunc) at a density of 3 ± 4610 4 cells/cm 2 and were DNA-transfected in the same way as that for CAT activity assay. Two days after transfection, cells were ®xed by methanol/acetone (1:1) at 7208C for 3.5 min, then subjected to the reactions with the ®rst antibody [rabbit anti-X peptide antiserum U23 (Takada and Koike, 1994) and mouse anti-p53 monoclonal antibody PAb 1801 (Oncogene Science)] and the second antibody [Texas Red goat anti-rabbit IgG (Vector Inc.) and¯uoresceinated goat anti-mouse IgG (Oncogene Science)] according to the manufacturer's instructions. Under a microscope more than 10 4 cells were examined in each slide at the magni®cation of 6100 and at least 100 dierent cells expressing p53 protein and/or X protein were analysed in detail at the magni®cation of 6200 or 6400. Subsequently, approximately 50 phase-contrast and fluorescent micrographs each were taken at the same magnification (6200 or 6400).
